“…The higher incidence and worse outcomes of parenchymal CNS tumors in male versus female patients, independent of age, race, tumor histology (including gliomas, ependymomas, and medulloblastomas), and country of residence/origin, has been reported in the literature. 3,30,35,37,46,52,58,63,70 Sun et al, in a review examining this disparity, postulated that it may be due to sexually dimorphic biology, specifically sex chromosome-based mechanisms of growth regulation. 63 Male embryos are larger, contain more cells, and show differential expression of genes important for glucose metabolism (G6PD and HPRT1), cellular growth (XIAP), and gene regulation (DMNT3A and DMNT3B); these differences are evident at the blastocyst stage, before gonadal differentiation at 8 weeks.…”